172 related articles for article (PubMed ID: 33086735)
21. Nuclear m(6)A Reader YTHDC1 Regulates mRNA Splicing.
Xiao W; Adhikari S; Dahal U; Chen YS; Hao YJ; Sun BF; Sun HY; Li A; Ping XL; Lai WY; Wang X; Ma HL; Huang CM; Yang Y; Huang N; Jiang GB; Wang HL; Zhou Q; Wang XJ; Zhao YL; Yang YG
Mol Cell; 2016 Feb; 61(4):507-519. PubMed ID: 26876937
[TBL] [Abstract][Full Text] [Related]
22. Factors affecting the expression and stability of full-length and truncated SRSF3 proteins in human cancer cells.
Sue SH; Liu ST; Huang SM
Sci Rep; 2024 Jun; 14(1):14397. PubMed ID: 38909100
[TBL] [Abstract][Full Text] [Related]
23. Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese hamster V-79 cells.
Hennig EE; Conney AH; Wei SJ
Cancer Res; 1995 Apr; 55(7):1550-8. PubMed ID: 7882364
[TBL] [Abstract][Full Text] [Related]
24. Regulated splicing of large exons is linked to phase-separation of vertebrate transcription factors.
Kawachi T; Masuda A; Yamashita Y; Takeda JI; Ohkawara B; Ito M; Ohno K
EMBO J; 2021 Nov; 40(22):e107485. PubMed ID: 34605568
[TBL] [Abstract][Full Text] [Related]
25. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
Fraile-Bethencourt E; Díez-Gómez B; Velásquez-Zapata V; Acedo A; Sanz DJ; Velasco EA
PLoS Genet; 2017 Mar; 13(3):e1006691. PubMed ID: 28339459
[TBL] [Abstract][Full Text] [Related]
26. Splicing factor SRSF3 represses translation of p21
Kim J; Park RY; Kee Y; Jeong S; Ohn T
Cell Death Dis; 2022 Nov; 13(11):933. PubMed ID: 36344491
[TBL] [Abstract][Full Text] [Related]
27. Interference with the HSF1/HSP70/BAG3 Pathway Primes Glioma Cells to Matrix Detachment and BH3 Mimetic-Induced Apoptosis.
Antonietti P; Linder B; Hehlgans S; Mildenberger IC; Burger MC; Fulda S; Steinbach JP; Gessler F; Rödel F; Mittelbronn M; Kögel D
Mol Cancer Ther; 2017 Jan; 16(1):156-168. PubMed ID: 27777286
[TBL] [Abstract][Full Text] [Related]
28. Oncogenic SRSF3 in health and diseases.
Jia R; Zheng ZM
Int J Biol Sci; 2023; 19(10):3057-3076. PubMed ID: 37416784
[TBL] [Abstract][Full Text] [Related]
29. Activation of Cryptic 3' Splice-Sites by SRSF2 Contributes to Cassette Exon Skipping.
Moon H; Jang HN; Liu Y; Choi N; Oh J; Ha J; Zheng X; Shen H
Cells; 2019 Jul; 8(7):. PubMed ID: 31295920
[TBL] [Abstract][Full Text] [Related]
30. SRSF3 and HNRNPH1 Regulate Radiation-Induced Alternative Splicing of Protein Arginine Methyltransferase 5 in Hepatocellular Carcinoma.
Wen C; Tian Z; Li L; Chen T; Chen H; Dai J; Liang Z; Ma S; Liu X
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499164
[TBL] [Abstract][Full Text] [Related]
31. Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA.
Kondo S; Yamamoto N; Murakami T; Okumura M; Mayeda A; Imaizumi K
Genes Cells; 2004 Feb; 9(2):121-30. PubMed ID: 15009090
[TBL] [Abstract][Full Text] [Related]
32. SRSF2 directly inhibits intron splicing to suppresses cassette exon inclusion.
Moon H; Cho S; Loh TJ; Jang HN; Liu Y; Choi N; Oh J; Ha J; Zhou J; Cho S; Kim DE; Ye MB; Zheng X; Shen H
BMB Rep; 2017 Aug; 50(8):423-428. PubMed ID: 28712387
[TBL] [Abstract][Full Text] [Related]
33. RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons and is itself regulated by lysine mono-methylation.
Carlson SM; Soulette CM; Yang Z; Elias JE; Brooks AN; Gozani O
J Biol Chem; 2017 Aug; 292(32):13381-13390. PubMed ID: 28655759
[TBL] [Abstract][Full Text] [Related]
34. SRSF3: Newly discovered functions and roles in human health and diseases.
More DA; Kumar A
Eur J Cell Biol; 2020 Aug; 99(6):151099. PubMed ID: 32800280
[TBL] [Abstract][Full Text] [Related]
35. SRSF3 promotes pluripotency through
Ratnadiwakara M; Archer SK; Dent CI; Ruiz De Los Mozos I; Beilharz TH; Knaupp AS; Nefzger CM; Polo JM; Anko ML
Elife; 2018 May; 7():. PubMed ID: 29741478
[TBL] [Abstract][Full Text] [Related]
36. Identification of SRSF3 target mRNAs using inducible TRIBE.
Jin S; Xue Z; Zhang J; Wang Z; Zhang J; Chen D; Liu W; Lin J
Biochem Biophys Res Commun; 2021 Nov; 578():21-27. PubMed ID: 34534741
[TBL] [Abstract][Full Text] [Related]
37. Characterization of cis-acting elements that control oscillating alternative splicing.
Goldammer G; Neumann A; Strauch M; Müller-McNicoll M; Heyd F; Preußner M
RNA Biol; 2018; 15(8):1081-1092. PubMed ID: 30200840
[TBL] [Abstract][Full Text] [Related]
38. Myosin heavy chain is stabilized by BCL-2 interacting cell death suppressor (BIS) in skeletal muscle.
Hong J; Park JS; Lee H; Jeong J; Hyeon Yun H; Yun Kim H; Ko YG; Lee JH
Exp Mol Med; 2016 Apr; 48(4):e225. PubMed ID: 27034027
[TBL] [Abstract][Full Text] [Related]
39. Partial deletion of a dystrophin gene leads to exon skipping and to loss of an intra-exon hairpin structure from the predicted mRNA precursor.
Matsuo M; Nishio H; Kitoh Y; Francke U; Nakamura H
Biochem Biophys Res Commun; 1992 Jan; 182(2):495-500. PubMed ID: 1734864
[TBL] [Abstract][Full Text] [Related]
40. The SRSF3-MBNL1-Acin1 circuit constitutes an emerging axis to lessen DNA fragmentation in colorectal cancer via an alternative splicing mechanism.
Chen YS; Liu CW; Lin YC; Tsai CY; Yang CH; Lin JC
Neoplasia; 2020 Dec; 22(12):702-713. PubMed ID: 33142236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
